⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Mark GoldsteinMD

Rheumatology · Staten Island, NY 10301

NPI: 1679568885

Share:

37

🟠 Elevated

Risk Flags

Very high opioid rate vs specialty peersHigh cost outlier (population + peer)High long-acting opioid rate vs peers

Risk indicators are statistical patterns, not allegations. Learn more

5,406

Total Claims

$7.1M

Drug Cost

452

Beneficiaries

$16K

Cost/Patient

Risk Score Breakdown 37/100

Low (0)Moderate (15)Elevated (30)High (50+)
Opioid rate vs specialty peers+18
Long-acting opioid rate+8
Cost per patient outlier+6

Score components are additive. Read full methodology

Peer Comparison vs. 5,101 Rheumatology providers

+422%

Opioid rate vs peers

21.2% vs 4.1% avg

+161%

Cost per patient vs peers

$16K vs $6,039 avg

⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.

🔎 Data Overview

💊

Opioid rate is 422% above Rheumatology peers. This is a significant deviation that may reflect a specialized patient population or concerning prescribing patterns.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Opioid Prescribing

21.2%

Opioid Rate

1,146

Opioid Claims

$109K

Opioid Cost

24.4%

Long-Acting Rate

This provider's opioid prescribing rate of 21.2% is above the 20% threshold that CMS considers elevated.

Brand vs Generic

100% generic

Brand: 0 claims · $0

Generic: 4,297 claims · $225K

Patient Profile

72

Avg Age

73%

Female

1.50

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About